| MiRNA | Compound | Condition | Effect | Throughput | PMID | Details |
|---|---|---|---|---|---|---|
| miR-22 | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 18645025 | |
| miR-221 | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 18645025 | |
| miR-222 | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 18645025 | |
| miR-224 | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 18645025 | |
| miR-22 | Doxorubicin (Adriamycin) | breast cancer | Sensitive | High | 18971180 | |
| miR-221 | Doxorubicin (Adriamycin) | breast cancer | Sensitive | High | 18971180 | |
| miR-222 | Doxorubicin (Adriamycin) | breast cancer | Sensitive | High | 18971180 | |
| miR-220 | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 19412672 | |
| miR-221 | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 19412672 | |
| miR-221 | Doxorubicin (Adriamycin) | leukemia | Sensitive | High | 21122348 | |
| miR-22 | Doxorubicin (Adriamycin) | hepatocellular cancer | Resistant | High | 23229111 | |
| miR-2277 | Doxorubicin (Adriamycin) | hepatocellular cancer | Resistant | High | 23359607 | |
| miR-22 | Doxorubicin (Adriamycin) | gastric cancer | Sensitive | High | 23525256 | |
| miR-223 | Doxorubicin (Adriamycin) | esophageal adenocarcinoma | Sensitive | Low | 23757351 | |
| miR-223 | Doxorubicin (Adriamycin) | hepatocellular carcinoma | Sensitive | Low | 23925649 | |
| miR-222 | Doxorubicin (Adriamycin) | breast cancer | Resistant | Low | 23994196 | |
| miR-221 | Doxorubicin (Adriamycin) | hepatocellular carcinoma | Resistant | Low | 24324033 | |
| miR-223 | Doxorubicin (Adriamycin) | breast cancer | Sensitive | Low | 24400121 | |
| miR-22 | Doxorubicin (Adriamycin) | osteosarcoma | Sensitive | Low | 24609901 | |
| miR-222 | Doxorubicin (Adriamycin) | breast cancer | Resistant | Low | 24740415 | |
| miR-224 | Doxorubicin (Adriamycin) | diffuse large B cell lymphoma (DLBCL) | Resistant | High | 24858372 | |
| miR-222 | Doxorubicin (Adriamycin) | breast cancer | Sensitive | High | 25562151 | |
| miR-224 | Doxorubicin (Adriamycin) | breast cancer | Sensitive | Low | 26701615 |